Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001567619-15-001306
Filing Date
2015-09-30
Accepted
2015-09-30 20:50:17
Documents
2
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 3 s001053x6_form3.html 3  
1 FORM 3 s001053x6_form3.xml 3 4292
2 POWER OF ATTORNEY s001053x6_ex24-1.htm EX-24.1 7117
  Complete submission text file 0001567619-15-001306.txt   12795
Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Issuer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CONNELL DRIVE SUITE 1600 BERKELEY HEIGHTS NJ 07922
Business Address
Vaish Renu (Reporting) CIK: 0001653001 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37568 | Film No.: 151135154